CT-based myocardial perfusion imaging-practical considerations: acquisition, image analysis, interpretation, and

Vishal C Mehra1, Marietta Ambrose, Carolina Valdiviezo-Schlomp

  • 1Department of Medicine, Division of Cardiology, Johns Hopkins University, 600 N. Wolfe Street, Carnegie Building 565C, Baltimore, MD 21287, USA.

Insights

New CT-based myocardial perfusion imaging (CTP), combined with CT angiography (CTA), offers a comprehensive, non-invasive cardiac risk assessment strategy. This approach integrates anatomical and functional data for improved patient stratification.

Area of Science:

  • Cardiology
  • Radiology
  • Medical Imaging

Background:

  • Non-invasive cardiac risk assessment traditionally uses exercise or pharmacological stress testing.
  • CT angiography (CTA) effectively differentiates coronary artery disease risk.
  • Advancements in CT technology enable CT-based myocardial perfusion imaging (CTP) for functional assessment.

Purpose of the Study:

  • To review the research, implementation, and analysis methods for CT-based myocardial perfusion imaging (CTP).
  • To discuss the current technological state and challenges of CTP.
  • To highlight the integration of CTA and CTP in multicenter studies like CORE320 for comprehensive risk assessment.

Main Methods:

  • Review of existing literature on CT-based cardiac risk assessment modalities.
  • Discussion of quantitative, semiquantitative, and qualitative image analysis techniques for CTP.
  • Examination of the CORE320 study evaluating combined CTA and CTP against reference standards.

Main Results:

  • CTP provides functional information complementing anatomical data from CTA.
  • Combined CTA and CTP strategies show promise for comprehensive cardiac risk assessment.
  • The CORE320 study investigates this combined approach against established methods.

Conclusions:

  • CT-based myocardial perfusion imaging (CTP) represents a significant advancement in non-invasive cardiac risk assessment.
  • Integrating CTA and CTP offers a powerful, comprehensive strategy for evaluating coronary artery disease.
  • Further research and validation, such as through the CORE320 study, are crucial for widespread clinical adoption.